Homepage > Company > Media > Blog > 2021 > DNA ENCODED LIBRARIES-CDI-CAPABILITIES

DNA ENCODED LIBRARIES-CDI-CAPABILITIES

ChemDiv proposes design and synthesis of heterocyclic scaffolds for DNA Encoded Libraries-CDI-Capabilities:

• Vast diversity of heterocyclic scaffolds
• Proprietary and continuously validated reactions and library protocols
• High Fsp3 scaffolds
- Flexible and conformationally constrained cores
- Derivatives and mimics of natural compounds
- Poly-functional derivatization

• Multiple diversity points, ≥ 3
• Defined chirality
- Confirmed relative stereochemistry
- Confirmed absolute stereochemistry

• Protein-Protein Interaction modulation as a focus:
- Macrocycles
- Spiro-cycles
- Natural templates

More details ⬇
https://store.chemdiv.com/catalog/custom_chemistry/dna_encoded_libraries_cdi_capabilities/

Read also

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

ChemDiv,Inc.

Science & Nature reviews, August 2021 (2)

These are ChemDiv's reviews on Nature and Science Journal articles.

OCULAR DISEASES SMALL MOLECULES LIBRARY

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.